Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.94 |
Change
-0.040(0.20%) |
Mkt cap ! $2.548B |
Open | High | Low | Value | Volume |
$19.92 | $20.04 | $19.51 | $4.745M | 239.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 198 | $19.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.94 | 1256 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 396 | 19.860 |
1 | 126 | 19.800 |
1 | 5329 | 19.750 |
1 | 1146 | 19.740 |
3 | 1798 | 19.720 |
Price($) | Vol. | No. |
---|---|---|
19.940 | 1009 | 1 |
19.970 | 150 | 1 |
19.990 | 1232 | 1 |
20.000 | 1811 | 4 |
20.030 | 1232 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online